|
1
|
Palella FJ Jr, Delaney KM, Moorman AC,
Loveless MO, Fuhrer J, Satten GA, Aschman DJ and Holmberg SD:
Declining morbidity and mortality among patients with advanced
human immunodeficiency virus infection. HIV Outpatient Study
Investigators. N Engl J Med. 338:853–860. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Kunitomi A, Hasegawa Y, Lmamura J,
Yokomaku Y, Tokunaga T, Miyata Y, Iida H and Nagai H: Acute
promyelocytic leukemia and HIV: Case reports and a review of the
literature. Intern Med. 58:2387–2391. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Gupta V, Shariff M, Bajwa R, Patel I,
Ayyad HA, Levitt MJ, Mencel PJ and Hossain MA: Acute myeloid
leukemia acquiring promyelocytic leukemia-retinoic acid receptor
alpha at relapse. World J Oncol. 10:153–156. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Mahmoud A, Ghrewati M, Kania B, Naseer M,
Kapoor A and Michael P: Aleukemic acute promyelocytic leukemia: How
Concomitant HIV, Hepatitis C, and chronic alcohol use disorder may
have hidden an underlying malignancy. Am J Case Rep.
24:e9380862023. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Korsos V and Miller WH Jr: How retinoic
acid and arsenic transformed acute promyelocytic leukemia therapy.
J Mol Endocrinol. 69:T69–T83. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Drilon AD, Gamboa EO, Koolaee R and Goel
A: Acute promyelocytic leukemia in HIV-infected adults: A case
report and review of therapeutic considerations. Clin Lymphoma
Myeloma Leuk. 10:E47–E52. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Mendes-de-Almeida DP, Fernandez TS,
Lovatel VL, da Rocha MM, Gomes BE, Monte-Mór BCR, Vianna DT,
Alcoforado MTG, Kronemberg JMPB, Cardoso JPSC, et al: Acute
promyelocytic leukemia in a long-standing HIV-positive patient:
Case report and literature review. Leuk Res Rep.
18:1003392022.PubMed/NCBI
|
|
8
|
Calvo R, Ribera JM, Battle M, Sancho JM,
Granada I, Flores A, Millá F and Feliu E: Acute promyelocytic
leukemia in a HIV seropositive patient. Leuk Lymphoma. 26:621–624.
1997. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Gatphoh ED, Zamzachin G, Devi SB and
Punyabati P: AIDS related malignant disease at regional institute
of medical sciences. Indian J Pathol Microbiol. 44:1–4.
2001.PubMed/NCBI
|
|
10
|
Sutton L, Guénel P, Tanguy ML, Rio B,
Dhedin N, Casassus P and Lortholary O; French Study Group on Acute
Myeloid Leukaemia in HIV–Infected Patients, : Acute myeloid
leukaemia in human immunodeficiency virus-infected adults:
Epidemiology, treatment feasibility and outcome. Br J Haematol.
112:900–908. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Kudva GC, Maliekel K, Richart JM, Batanian
JR, Grosso LE, Sokol-Anderson M and Petruska PJ: Acute
promyelocytic leukemia and HIV-1 infection: Case report and review
of the literature. Am J Hematol. 77:287–290. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
De Vita S, De Matteis S, Laurenti L, Sorà
F, Tarnani M, Cingolani A and Sica S: Acute promyelocytic leukemia
in an HIV-infected patient: A case report. Am J Hematol.
81:3002006. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Boban A, Radman I, Zadro R, Dubravcic K,
Maretic T, Civljak R, Lisic M and Begovac J: Acute promyelocytic
leukemia after whole brain irradiation of primary brain lymphoma in
an HIV-infected patient. Eur J Med Res. 14:42–43. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Malik A and Levine RL: The First Case
Report of APL (Acute Promyelocytic Leukemia) in An HIV Positive
Patient On (Highly Active Antiretroviral Therapy) Treated with
Arsenic Trioxide. Blood. 114:41662009. View Article : Google Scholar
|
|
15
|
Wu P, Sun W and Li J: Rheumatoid arthritis
patients with peripheral blood cell reduction should be evaluated
for latent Felty syndrome: A case report. Medicine (Baltimore).
99:e236082020. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Wang C, Liao Q, Hu Y and Zhong D: T
lymphocyte subset imbalances in patients contribute to ankylosing
spondylitis. Exp Ther Med. 9:250–256. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Caprodossi S, Pedinotti M, Amantini C,
Santoni G, Minucci S, Pelicci PG and Fanelli M: Differentiation
response of acute promyelocytic leukemia cells and PML/RARa
leukemogenic activity studies by real-time RT-PCR. Mol Biotechnol.
30:231–238. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Bolduc P, Roder N, Colgate E and Cheeseman
SH: Care of patients With HIV infection: Medical complications and
comorbidities. FP Essent. 443:16–22. 2016.PubMed/NCBI
|
|
19
|
Monroe J and Godwin JH: HIV/AIDS case
histories: Acute leukemia in an AIDS patient. AIDS Patient Care
STDS. 14:221–223. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Forghieri F, Nasillo V, Bettelli F, Pioli
V, Giusti D, Gilioli A, Mussini C, Tagliafico E, Trenti T,
Cossarizza A, et al: Acute myeloid leukemia in patients living with
HIV Infection: Several questions, fewer answers. Int J Mol Sci.
21:10812020. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Aboulafia DM, Meneses M, Ginsberg S,
Siegel MS, Howard WW and Dezube BJ: Acute myeloid leukemia in
patients infected with HIV-1. AIDS. 16:865–876. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Kane D, Keating S, McCann S and Mulcahy F:
The management of acute myeloid leukaemia (AML) in human
immunodeficiency virus (HIV) infection: A case report and review.
Int J STD AIDS. 8:272–274. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Katsura M, Okuhama A, Koizumi Y, Ando N,
Yanagawa Y, Mizushima D, Aoki T, Tsukada K, Teruya K, Kikuchi Y, et
al: Progressive cytopenia developing during treatment of
cryptococcosis in a patient with HIV infection and bone marrow
cryptococcal infection. Intern Med. 61:257–261. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Labrador J, Luño E, Vellenga E, Brunet S,
González-Campos J, Chillón MC, Holowiecka A, Esteve J, Bergua J,
González-Sanmiguel JD, et al: Clinical significance of complex
karyotype at diagnosis in pediatric and adult patients with de novo
acute promyelocytic leukemia treated with ATRA and chemotherapy.
Leuk Lymphoma. 60:1146–1155. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Wiernik PH, Sun Z, Gundacker H, Dewald G,
Slovak ML, Paietta E, Kim HT, Appelbaum FR, Cassileth PA and
Tallman MS: Prognostic implications of additional chromosome
abnormalities among patients with de novo acute promyelocytic
leukemia with t(15;17). Med Oncol. 29:2095–2101. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Lai BB, Mu QT, Zhang YL, Chen Y and Ouyang
GF: Effect of Chromosomal Karyotype on the Prognosis of Patients
with Acute Promyelocytic Leukemia in Condition of the Maintenance
Treatment Based on Arsenic Trioxide. Zhongguo Shi Yan Xue Ye Xue Za
Zhi. 27:1380–1386. 2019.(In Chinese). PubMed/NCBI
|
|
27
|
Wan TS, Ma SK, Au WY, Liu HS, Chan JC and
Chan LC: Trisomy 21 and other chromosomal abnormalities in acute
promyelocytic leukemia. Cancer Genet Cytogenet. 140:170–173. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Vu MP, Nguyen CN and Vu H: Cytogenetic
influence on prognosis in acute promyelocytic leukaemia: A cohort
study in vietnam. Hematol Oncol Stem Cell Ther. 15:151–153.
2022.PubMed/NCBI
|
|
29
|
Epstein-Peterson ZD, Derkach A, Geyer S,
Mrózek K, Kohlschmidt J, Park JH, Rajeeve S, Stein EM, Zhang Y,
Iland H, et al: Effect of additional cytogenetic abnormalities on
survival in arsenic trioxide-treated acute promyelocytic leukemia.
Blood Adv. 6:3433–3439. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Cingam SR and Koshy NV: Acute
Promyelocytic Leukemia. 2022 Jun 27. StatPearls [Internet].
StatPearls Publishing; Treasure Island, FL: 2023
|
|
31
|
Rosenbaum MW, Pozdnyakova O, Geyer JT, Dal
Cin P and Hasserjian RP: Ring chromosome in myeloid neoplasms is
associated with complex karyotype and disease progression. Hum
Pathol. 68:40–46. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Stahl M and Tallman MS: Acute
promyelocytic leukemia (APL): Remaining challenges towards a cure
for all. Leuk Lymphoma. 60:3107–3115. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Avvisati G, Lo-Coco F, Paoloni FP, Petti
MC, Diverio D, Vignetti M, Latagliata R, Specchia G, Baccarani M,
Di Bona E, et al: GIMEMA, AIEOP, and EORTC Cooperative Groups. AIDA
0493 protocol for newly diagnosed acute promyelocytic leukemia:
Very long-term results and role of maintenance. Blood.
117:4716–4725. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Diep R and Metjian A: A rare CALR variant
mutation and a review of CALR in essential thrombocythemia. J
Thromb Thrombolysis. 45:457–462. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Li Y, Liu X, Chen H, Xie P, Ma R, He J and
Zhang H: Bioinformatics analysis for the role of CALR in human
cancers. PLoS One. 16:e02612542021. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Martins I, Kepp O, Galluzzi L, Senovilla
L, Schlemmer F, Adjemian S, Menger L, Michaud M, Zitvogel L and
Kroemer G: Surface-exposed calreticulin in the interaction between
dying cells and phagocytes. Ann N Y Acad Sci. 1209:77–82. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Papp S, Fadel MP, Kim H, McCulloch CA and
Opas M: Calreticulin affects fibronectin-based cell-substratum
adhesion via the regulation of c-Src activity. J Biol Chem.
282:16585–16598. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Merlinsky TR, Levine RL and Pronier E:
Unfolding the role of calreticulin in myeloproliferative neoplasm
pathogenesis. Clin Cancer Res. 25:2956–2962. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Zhao Z, Chen CC, Rillahan CD, Shen R,
Kitzing T, McNerney ME, Diaz-Flores E, Zuber J, Shannon K, Le Beau
MM, et al: Cooperative loss of RAS feedback regulation drives
myeloid leukemogenesis. Nat Genet. 47:539–543. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Kayser S, Feszler M, Krzykalla J, Schick
M, Kramer M, Benner A, Thol F, Platzbecker U, Müller-Tidow C, Ho
AD, et al: Clinical impact of KMT2C and SPRY4 expression levels in
intensively treated younger adult acute myeloid leukemia patients.
Eur J Haematol. 99:544–552. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Garg M, Nagata Y, Kanojia D, Mayakonda A,
Yoshida K, Haridas Keloth S, Zang ZJ, Okuno Y, Shiraishi Y, Chiba
K, et al: Profiling of somatic mutations in acute myeloid leukemia
with FLT3-ITD at diagnosis and relapse. Blood. 126:2491–2501. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Ciftciler R, Haznedaroglu IC, Aksu S,
Ozcebe O, Sayınalp N, Malkan UY and Buyukasık Y: The factors
affecting early death in newly diagnosed apl patients. Open Med
(Wars). 14:647–652. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
O'Donnell MR, Tallman MS, Abboud CN,
Altman JK, Appelbaum FR, Arber DA, Attar E, Borate U, Coutre SE,
Damon LE, et al: National Comprehensive Cancer Network. Acute
myeloid leukemia, version 2.2013. J Natl Compr Canc Netw.
11:1047–1055. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Li X, Wang C, Chen G, Ji B and Xu Y:
Combined chemotherapy for acute promyelocytic leukemia: A
meta-analysis. Hematology. 22:450–459. 2017.PubMed/NCBI
|
|
45
|
Xiao M, Zhou P, Liu Y, Wei S, Li D, Li W,
Niu X, Niu J, Zhang Y, Cao W, et al: Predictive factors for
differentiating thrombohemorrhagic disorders in high-risk acute
promyelocytic leukemia. Thromb Res. 210:33–41. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Jillella AP and Kota VK: The global
problem of early deaths in acute promyelocytic leukemia: A strategy
to decrease induction mortality in the most curable leukemia. Blood
Rev. 32:89–95. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Pei Y, Shi M, Song J, Niu X, Wei S, Dou L,
Xiao M, Li D, Xu F, Bai Y and Sun K: Absolute circulating leukemic
cells as a risk factor for early bleeding events in patients with
non-high-risk acute promyelocytic leukemia. Cancer Manag Res.
13:4135–4146. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Saris A and Pavenski K: Human leukocyte
antigen alloimmunization and alloimmune platelet refractoriness.
Transfus Med Rev. 34:250–257. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Prodger CF, Rampotas A, Estcourt LJ,
Stanworth SJ and Murphy MF: Platelet transfusion: Alloimmunization
and refractoriness. Semin Hematol. 57:92–99. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Trinkley KE, Page RL II, Lien H, Yamanouye
K and Tisdale JE: QT interval prolongation and the risk of torsades
de pointes: Essentials for clinicians. Curr Med Res Opin.
29:1719–1726. 2013. View Article : Google Scholar : PubMed/NCBI
|
